Neogenomics Inc. (NEO) Rapporto sugli Utili - Previsioni e Surprise Ratio

Pubblicita'

Storico dei ricavi trimestrali

NEO rapporto: 62%

100%

NEO supera 21 di 34 ultime stime

Data del prossimo reportNov 5, 2024

Stimato per Q3 24:$-0.05

Cambiamenti implicati per il Q2 24:+25.00%

Cambiamenti implicati per il Q3 23:-16.67%

Periodo Bilanci	Data Riportata	EPS / Previsioni	Sorpresa
Q2 24	Jul 29, 2024	$-0.04 / $-0.05	$0.01 / 20%
Q1 24	Apr 30, 2024	$-0.08 / $-0.07	$-0.01 / -14.29%
Q4 23	Feb 20, 2024	$-0.02 / $-0.07	$0.05 / 71.43%
Q3 23	Nov 6, 2023	$-0.06 / $-0.11	$0.05 / 45.45%
Q2 23	Aug 8, 2023	$-0.09 / $-0.15	$0.06 / 40%
Q1 23	May 8, 2023	$-0.13 / $-0.16	$0.03 / 18.75%
Q4 22	Feb 23, 2023	$-0.1 / $-0.19	$0.09 / 47.37%
Q3 22	Nov 8, 2022	$-0.17 / $-0.23	$0.06 / 26.09%

Fornitori di Dati: Xignite Logo